Andale , Khurt Rendelle .
HRN: 25-13-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2024
CEFTRIAXONE 1G (VIAL)
12/25/2024
01/01/2025
IV
1.3gms
OD
PCAP D
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes